Leaflet FRISIUM 10mg tablets


Indicated for: epilepsy

Substance: clobazam (benzodiazepine)

ATC: N05BA09 (Nervous system | Anxiolytics | Benzodiazepine derivatives)

Clobazam is a medication used to treat anxiety disorders and epilepsy, particularly Lennox-Gastaut syndrome. It belongs to the benzodiazepine class and works by enhancing the effect of a neurotransmitter called gamma-aminobutyric acid (GABA), which helps reduce excessive brain activity.

The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important not to abruptly stop the treatment, as this may lead to withdrawal symptoms.

Side effects may include drowsiness, dizziness, fatigue, or confusion. In rare cases, severe adverse effects such as respiratory depression or dependency may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as liver diseases or depression, as these may affect the safety of clobazam use.

General data about FRISIUM 10mg

  • Substance: clobazam
  • Date of last drug list: 01-03-2026
  • Commercial code: W62769001
  • Concentration: 10mg
  • Pharmaceutical form: tablets
  • Quantity: 100
  • Product type: original
  • Prescription restrictions: TAB3 - Medicines that are issued with a special prescription (psychotropic) in green color.

Marketing authorisation

  • Manufacturer: SANOFI WINTHROP INDUSTRIE - FRANTA
  • Holder: CN UNIFARM S.A. - ROMANIA
  • Number: 481/2020/01
  • Shelf life: 3 years